Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model.
Teranishi
K
K
Department of Thoracic Surgery, Nagoya University, Japan.
Poston
R S
RS
Tsao
P S
PS
Asagami
T
T
Cooke
J P
JP
Reitz
B A
BA
Robbins
R C
RC
D000818:Animals; D003324:Coronary Artery Disease / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009566:Nitrates / Q000097:blood; D009573:Nitrites / Q000097:blood; D011183:Postoperative Complications; D051381:Rats; D011912:Rats, Inbred ACI; D016042:Transplantation, Heterotopic; D014185:Transplantation, Isogeneic / Q000276:immunology* / Q000473:pathology / Q000502:physiology
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D007166:Immunosuppressive Agents; D009566:Nitrates; D009573:Nitrites; D016572:Cyclosporine